GlassScriptPhysician profile
Amir M Rizvi
NPI 1992806129
$886.36
in general payments reported to CMS, 2019-2025
12 companies · $533 in 2025
The $533 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $133 · 2024: $220 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $886.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $173.38 | 2023-2025 | Uzedy |
| E.R. Squibb & Sons, L.L.C. | $165.79 | 2024-2025 | Cobenfy |
| Otsuka America Pharmaceutical, INC. | $118.07 | 2025 | Abilify Asimtufii, Abilify Maintena |
| Abbvie INC. | $96.89 | 2023-2025 | Vraylar |
| Indivior INC. | $92.79 | 2023-2024 | Perseris |
| Lundbeck LLC | $92.12 | 2023-2025 | Rexulti |
| Alkermes, INC. | $39.39 | 2024-2025 | Lybalvi, Aristada |
| Janssen Pharmaceuticals, INC | $37.51 | 2024-2025 | Spravato, Invega Trinza, Invega Sustenna |
| Tempus Ai, INC | $18.67 | 2024 | |
| Luye Pharma (USA) LTD. | $18.05 | 2025 | Erzofri Extended-Release |
| Almatica Pharma LLC | $17.00 | 2024 | Loreev Xr |
| Vanda Pharmaceuticals INC. | $16.70 | 2024 | Fanapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Rizvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.